NanoString Technologies has developed a compact, mobile digital spatial profiling system for imaging regions-of-interest (ROIs) in tissue samples. The system includes UV light for photocleaving oligos ...
These authors contributed equally to this work. Oestrogen receptor positive/ human epidermal growth factor receptor positive (ER+/HER2+) breast cancers (BCs) are less responsive to endocrine therapy ...
NanoString, which has been acquired by Bruker, has won a victory in a patent battle with 10x Genomics. Billerica, MA-based Bruker said that the German Federal Patent Court has ruled in favor of ...
A little more than two months ago, NanoString Technologies filed for bankruptcy – weary from having to pay $31 million to 10X Genomics after losing a patent infringement lawsuit. Today is a different ...
More than two months after filing for Chapter 11, NanoString Technologies has found a buyer in Bruker, which will acquire substantially all the bankrupt company’s assets for approximately $392.6 ...
Scientific instruments maker Bruker will pay about $392.6 million in cash to acquire most of the assets of Nanostring, a provider of research tools for spatial biology and gene expression, Nanostring ...
NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) NanoString announced Wednesday that it will be acquired by Bruker, ending the ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that ...
Seattle-based NanoString said the debtor-in-possession financing will help the company as it restructures. Seattle-based research device company NanoString Technologies Inc. (Nasdaq: NSTG) has secured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results